1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Dermocosmetics Skin Care Products Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Dermocosmetics Skin Care Products Market, by Product Type
8.1.1. Facial Care
8.1.1.1. Market Revenue and Forecast
8.1.2. Hair Care
8.1.2.1. Market Revenue and Forecast
8.1.3. Body Care
8.1.3.1. Market Revenue and Forecast
8.1.4. Suncare
8.1.4.1. Market Revenue and Forecast
8.1.5. Lip & Eye Care
8.1.5.1. Market Revenue and Forecast
8.1.6. Others
8.1.6.1. Market Revenue and Forecast
9.1. Dermocosmetics Skin Care Products Market, by Skin Concern / Treatment Area
9.1.1. Acne & Blemishes
9.1.1.1. Market Revenue and Forecast
9.1.2. Anti-ageing / Wrinkles
9.1.2.1. Market Revenue and Forecast
9.1.3. Hyperpigmentation / Melasma
9.1.3.1. Market Revenue and Forecast
9.1.4. Rosacea & Redness
9.1.4.1. Market Revenue and Forecast
9.1.5. Psoriasis / Eczema
9.1.5.1. Market Revenue and Forecast
9.1.6. Sensitive / Reactive Skin
9.1.6.1. Market Revenue and Forecast
9.1.7. Dry / Dehydrated Skin
9.1.7.1. Market Revenue and Forecast
9.1.8. Oily / Combination Skin
9.1.8.1. Market Revenue and Forecast
9.1.9. Sun Protection / Sun Damage
9.1.9.1. Market Revenue and Forecast
9.1.10. Hair Loss & Scalp Conditions
9.1.10.1. Market Revenue and Forecast
9.1.11. Skin Barrier Disorders
9.1.11.1. Market Revenue and Forecast
10.1. Dermocosmetics Skin Care Products Market, by Active Ingredient Type
10.1.1. Botanicals & Natural Actives
10.1.1.1. Market Revenue and Forecast
10.1.2. Chemical Actives
10.1.2.1. Market Revenue and Forecast
10.1.3. Mineral-based Actives
10.1.3.1. Market Revenue and Forecast
10.1.4. Biological/Pharmaceutical Actives
10.1.4.1. Market Revenue and Forecast
11.1. Dermocosmetics Skin Care Products Market, by Distribution Channel
11.1.1. Pharmacy-Based Retail (OTC Pharmacies, Drugstores)
11.1.1.1. Market Revenue and Forecast
11.1.2. Dermatologist Clinics & Aesthetic Centres
11.1.2.1. Market Revenue and Forecast
11.1.3. Supermarkets / Hypermarkets
11.1.3.1. Market Revenue and Forecast
11.1.4. Beauty Speciality Stores (Sephora, Ulta, etc.)
11.1.4.1. Market Revenue and Forecast
11.1.5. Online / E-commerce
11.1.5.1. Market Revenue and Forecast
11.1.6. Direct-to-Consumer (D2C) Brands
11.1.6.1. Market Revenue and Forecast
11.1.7. Hospital / Clinical Distribution
11.1.7.1. Market Revenue and Forecast
12.1. Dermocosmetics Skin Care Products Market, by End User
12.1.1. Retail / General Public
12.1.1.1. Market Revenue and Forecast
12.1.2. Dermatology Clinics & Specialists
12.1.2.1. Market Revenue and Forecast
12.1.3. Plastic Surgery & Aesthetic Clinics
12.1.3.1. Market Revenue and Forecast
12.1.4. Hospitals
12.1.4.1. Market Revenue and Forecast
12.1.5. Beauty Salons & Spas
12.1.5.1. Market Revenue and Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Product Type
13.1.2. Market Revenue and Forecast, by Skin Concern / Treatment Area
13.1.3. Market Revenue and Forecast, by Active Ingredient Type
13.1.4. Market Revenue and Forecast, by Distribution Channel
13.1.5. Market Revenue and Forecast, by End User
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Product Type
13.1.6.2. Market Revenue and Forecast, by Skin Concern / Treatment Area
13.1.6.3. Market Revenue and Forecast, by Active Ingredient Type
13.1.6.4. Market Revenue and Forecast, by Distribution Channel
13.1.6.5. Market Revenue and Forecast, by End User
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Forecast, by Product Type
13.1.7.2. Market Revenue and Forecast, by Skin Concern / Treatment Area
13.1.7.3. Market Revenue and Forecast, by Active Ingredient Type
13.1.7.4. Market Revenue and Forecast, by Distribution Channel
13.1.7.5. Market Revenue and Forecast, by End User
13.2. Europe
13.2.1. Market Revenue and Forecast, by Product Type
13.2.2. Market Revenue and Forecast, by Skin Concern / Treatment Area
13.2.3. Market Revenue and Forecast, by Active Ingredient Type
13.2.4. Market Revenue and Forecast, by Distribution Channel
13.2.5. Market Revenue and Forecast, by End User
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Product Type
13.2.6.2. Market Revenue and Forecast, by Skin Concern / Treatment Area
13.2.6.3. Market Revenue and Forecast, by Active Ingredient Type
13.2.7. Market Revenue and Forecast, by Distribution Channel
13.2.8. Market Revenue and Forecast, by End User
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Product Type
13.2.9.2. Market Revenue and Forecast, by Skin Concern / Treatment Area
13.2.9.3. Market Revenue and Forecast, by Active Ingredient Type
13.2.10. Market Revenue and Forecast, by Distribution Channel
13.2.11. Market Revenue and Forecast, by End User
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Product Type
13.2.12.2. Market Revenue and Forecast, by Skin Concern / Treatment Area
13.2.12.3. Market Revenue and Forecast, by Active Ingredient Type
13.2.12.4. Market Revenue and Forecast, by Distribution Channel
13.2.13. Market Revenue and Forecast, by End User
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Product Type
13.2.14.2. Market Revenue and Forecast, by Skin Concern / Treatment Area
13.2.14.3. Market Revenue and Forecast, by Active Ingredient Type
13.2.14.4. Market Revenue and Forecast, by Distribution Channel
13.2.15. Market Revenue and Forecast, by End User
13.3. APAC
13.3.1. Market Revenue and Forecast, by Product Type
13.3.2. Market Revenue and Forecast, by Skin Concern / Treatment Area
13.3.3. Market Revenue and Forecast, by Active Ingredient Type
13.3.4. Market Revenue and Forecast, by Distribution Channel
13.3.5. Market Revenue and Forecast, by End User
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Product Type
13.3.6.2. Market Revenue and Forecast, by Skin Concern / Treatment Area
13.3.6.3. Market Revenue and Forecast, by Active Ingredient Type
13.3.6.4. Market Revenue and Forecast, by Distribution Channel
13.3.7. Market Revenue and Forecast, by End User
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Product Type
13.3.8.2. Market Revenue and Forecast, by Skin Concern / Treatment Area
13.3.8.3. Market Revenue and Forecast, by Active Ingredient Type
13.3.8.4. Market Revenue and Forecast, by Distribution Channel
13.3.9. Market Revenue and Forecast, by End User
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Product Type
13.3.10.2. Market Revenue and Forecast, by Skin Concern / Treatment Area
13.3.10.3. Market Revenue and Forecast, by Active Ingredient Type
13.3.10.4. Market Revenue and Forecast, by Distribution Channel
13.3.10.5. Market Revenue and Forecast, by End User
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Product Type
13.3.11.2. Market Revenue and Forecast, by Skin Concern / Treatment Area
13.3.11.3. Market Revenue and Forecast, by Active Ingredient Type
13.3.11.4. Market Revenue and Forecast, by Distribution Channel
13.3.11.5. Market Revenue and Forecast, by End User
13.4. MEA
13.4.1. Market Revenue and Forecast, by Product Type
13.4.2. Market Revenue and Forecast, by Skin Concern / Treatment Area
13.4.3. Market Revenue and Forecast, by Active Ingredient Type
13.4.4. Market Revenue and Forecast, by Distribution Channel
13.4.5. Market Revenue and Forecast, by End User
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Product Type
13.4.6.2. Market Revenue and Forecast, by Skin Concern / Treatment Area
13.4.6.3. Market Revenue and Forecast, by Active Ingredient Type
13.4.6.4. Market Revenue and Forecast, by Distribution Channel
13.4.7. Market Revenue and Forecast, by End User
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Product Type
13.4.8.2. Market Revenue and Forecast, by Skin Concern / Treatment Area
13.4.8.3. Market Revenue and Forecast, by Active Ingredient Type
13.4.8.4. Market Revenue and Forecast, by Distribution Channel
13.4.9. Market Revenue and Forecast, by End User
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Product Type
13.4.10.2. Market Revenue and Forecast, by Skin Concern / Treatment Area
13.4.10.3. Market Revenue and Forecast, by Active Ingredient Type
13.4.10.4. Market Revenue and Forecast, by Distribution Channel
13.4.10.5. Market Revenue and Forecast, by End User
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Product Type
13.4.11.2. Market Revenue and Forecast, by Skin Concern / Treatment Area
13.4.11.3. Market Revenue and Forecast, by Active Ingredient Type
13.4.11.4. Market Revenue and Forecast, by Distribution Channel
13.4.11.5. Market Revenue and Forecast, by End User
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Product Type
13.5.2. Market Revenue and Forecast, by Skin Concern / Treatment Area
13.5.3. Market Revenue and Forecast, by Active Ingredient Type
13.5.4. Market Revenue and Forecast, by Distribution Channel
13.5.5. Market Revenue and Forecast, by End User
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Product Type
13.5.6.2. Market Revenue and Forecast, by Skin Concern / Treatment Area
13.5.6.3. Market Revenue and Forecast, by Active Ingredient Type
13.5.6.4. Market Revenue and Forecast, by Distribution Channel
13.5.7. Market Revenue and Forecast, by End User
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Product Type
13.5.8.2. Market Revenue and Forecast, by Skin Concern / Treatment Area
13.5.8.3. Market Revenue and Forecast, by Active Ingredient Type
13.5.8.4. Market Revenue and Forecast, by Distribution Channel
13.5.8.5. Market Revenue and Forecast, by End User
14.1. Procter & Gamble
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. L’Oréal Groupe
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Unilever
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Johnson & Johnson Services, Inc.
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Shiseido Co., Limited
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Amorepacific
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Beiersdorf
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Kanebo Cosmetics Inc.
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Avon Products, Inc.
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Lotus Herbals Pvt. Ltd.
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client